Similar articles

• Review of Advances in Uroprotective Agents for Cyclophosphamide- and Ifosfamide-induced Hemorrhagic Cystitis.

  Matz EL, Hsieh MH. Matz EL, et al. Urology. 2017 Feb;100:16-19. doi: 10.1016/j.urology.2016.07.030. Epub 2016 Aug 24. Urology. 2017. PMID: 27566144 Review.
• The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.

  Andriole GL, Sandlund JT, Miser JS, Arasi V, Linehan M, Magrath IT. Andriole GL, et al. J Clin Oncol. 1987 May;5(5):799-803. doi: 10.1200/JCO.1987.5.5.799. J Clin Oncol. 1987. PMID: 3106585
• Ternatin, a flavonoid, prevents cyclophosphamide and ifosfamide-induced hemorrhagic cystitis in rats.

  Vieira MM, Macêdo FY, Filho JN, Costa AC, Cunha AN, Silveira ER, Brito GA, Ribeiro RA. Vieira MM, et al. Phytother Res. 2004 Feb;18(2):135-41. doi: 10.1002/ptr.1379. Phytother Res. 2004. PMID: 15022166
• Uroprotective effect of pentoxifylline in cyclophosphamide-induced hemorrhagic cystitis in rats.

  Abo-Salem OM. Abo-Salem OM. J Biochem Mol Toxicol. 2013 Jul;27(7):343-50. doi: 10.1002/jbt.21494. Epub 2013 May 20. J Biochem Mol Toxicol. 2013. PMID: 23695977
• Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation.

  Korkmaz A, Topal T, Oter S. Korkmaz A, et al. Cell Biol Toxicol. 2007 Sep;23(5):303-12. doi: 10.1007/s10565-006-0078-0. Epub 2007 Jan 15. Cell Biol Toxicol. 2007. PMID: 17225077 Review.